Tissue‐Agnostic Cellular Morphometric Biomarkers for Risk‐Adapted Management Across Gastrointestinal Precancerous Lesions and Cancers
A biologically transparent, tissue‐agnostic CMB framework that links conserved TME organization to clinically actionable risk assessment is established, providing a scalable approach for early cancer management and precision oncology.